HAL (France)open access
The Dual Role of Autophagy in Crizotinib-Treated ALK+ ALCL: From the Lymphoma Cells Drug Resistance to Their Demise
Anaplastic lymphoma kinase ALK, Crizotinib, 0, 2, Targeted therapy, Autophagy, Cell survival, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 213230
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.